Montis Biosciences

Foundation date

19/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Montis Biosciences’ mission is to therapeutically exploit cellular interactions between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors.

Montis Biociences was established based on the foundational science from the laboratories of Prof. Peter Carmeliet and Massimiliano Mazzone (VIB-KU Leuven), and is backed by an international syndicate of investors.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    13 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024